BRIACELL THERAPEUTICS CORP (BCT.CA) Stock Earnings & Estimates
TSX:BCT - CA1079302081 - Common Stock
10.69 CAD
+0.59 (+5.84%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | ||||||||||||
| EBITDA YoY % growth | -470K | N/A | -1.688M | -2.344M -38.90% | -3.613M -54.12% | -4.519M -25.08% | -3.547M 21.50% | -6.961M -96.22% | -15.274M -119.43% | -23.257M -52.27% | -33.246M -42.95% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -470K | -3.548M -654.98% | -1.689M 52.41% | -2.345M -38.83% | -3.625M -54.63% | -4.533M -25.04% | -3.561M 21.44% | -6.976M -95.89% | -15.289M -119.16% | -23.272M -52.22% | -33.33M -43.22% | N/A 22.79% | N/A -32.26% | N/A -27.89% | N/A | N/A | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -19.50 -26.19% | -4.50 76.92% | N/A 67.23% | N/A -21.23% | N/A -92.09% | N/A 54.12% | N/A 52.56% |
All data in USD
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | -14.04 -1,237.05% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -6.969M -20.78% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -16.40 -1,093.94% | -17.78 | 1.38 | 7.74% |
| Q2 2025 Q2Q % growth | -23.30 -118.78% | -19.59 | -3.71 | -18.91% |
| Q1 2025 Q2Q % growth | -3.30 -159.46% | -1.21 | -2.09 | -172.28% |
| Q4 2024 Q2Q % growth | -1.05 50.00% | -7.88 | 6.83 | 86.67% |
| Q3 2024 Q2Q % growth | 1.65 134.38% | -8.33 | 9.98 | 119.80% |
| Q2 2024 Q2Q % growth | -10.65 7.79% | -3.03 | -7.62 | -251.49% |
| Q1 2024 Q2Q % growth | 5.55 628.57% | -2.73 | 8.28 | 303.52% |
| Q4 2023 Q2Q % growth | -2.10 86.27% | -6.06 | 3.96 | 65.35% |
| Q3 2023 Q2Q % growth | -4.80 | -5.38 | 0.58 | 10.75% |
| Q2 2023 Q2Q % growth | -11.55 -220.83% | -5.38 | -6.17 | -114.75% |
| Q1 2023 Q2Q % growth | -1.05 | -5.00 | 3.95 | 79.00% |
| Q4 2022 Q2Q % growth | -15.30 | -4.62 | -10.68 | -231.12% |
| Q3 2022 Q2Q % growth | -4.80 | -2.88 | -1.92 | -66.75% |
| Q2 2022 Q2Q % growth | -3.60 | -2.50 | -1.10 | -44.01% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -900% | -900% | 72.11% | 72.11% |
| Revenue | N/A | N/A | N/A | N/A |